We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
164 hedge funds and large institutions have $1.1B invested in Rocket Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,036% more call options, than puts
Call options by funds: $10.2M | Put options by funds: $902K
121% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 14
60% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 40
23% more capital invested
Capital invested by funds: $892M → $1.1B (+$210M)
12% more funds holding
Funds holding: 147 → 164 (+17)
6.17% more ownership
Funds ownership: 98.41% → 104.58% (+6.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
164
Holders Change
+17
Holders Change %
+11.56%
% of All Funds
2.83%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
31
Increased
64
Reduced
40
Closed
14
Calls
$10.2M
Puts
$902K
Net Calls
+$9.34M
Net Calls Change
+$8.82M
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$13.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$13.4M |
| 3 |
Goldman Sachs
New York
|
+$8.33M |
| 4 |
BlackRock
New York
|
+$7.62M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$7.48M |
